Western blot analysis corroborated these findings, demonstrating that CX3CR1-deficient DCM mice had significantly reduced galectin-3 protein levels at both 5 and 10 weeks post-DCM compared to WT DCM mice (Figure 4D, n = 2–6/group). This evidence concerns the gene LGALS3 and familial dilated cardiomyopathy.